SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Japan Finds Roche Holding AG’s Tamiflu Study Inconclusive, Will Probe More
December 17, 2007
 · 
1 min read
Drug Development
Another ‘Smart’ Cancer Drug can Have Toxic Effects on the Heart
December 14, 2007
 · 
1 min read
Drug Development
Why Use Steroids? They Work
December 14, 2007
 · 
1 min read
Drug Development
Data Confirm Dasatinib’s Effectiveness in Resistant Chronic Myelogenous Leukemia, Dana-Farber Cancer Institute Study
December 14, 2007
 · 
1 min read
Drug Development
Venlafaxine Extended-Release Effective for Patients with Major Depression
December 13, 2007
 · 
1 min read
Drug Development
Combination Therapy Including Antibiotics May be Beneficial for Multiple Sclerosis
December 11, 2007
 · 
1 min read
Drug Development
Evidence Links Anemia Drugs With Leukemic Transformation in Patients with Primary Myelofibrosis, Mayo Clinic Study
December 11, 2007
 · 
1 min read
Drug Development
Dasatinib, Nilotinib Show Strong Early Results as Frontline Therapy for Chronic Myelogenous Leukemia, M. D. Anderson Cancer Center Study
December 10, 2007
 · 
1 min read
Drug Development
M. D. Anderson Cancer Center: Re-Engineered Gleevec Reduces Heart Risks; Modified Drug Just as Effective Against Gastrointestinal Cancer
December 10, 2007
 · 
1 min read
Drug Development
Oregon Health & Science University (OHSU): Gleevec, the Targeted Cancer Pill, Delivers More Good News to Patients
December 10, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Two Novartis AG Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
December 13, 2011
 · 
23 min read
Drug Development
Celgene International Sárl Release: Final Data from Phase II Multi-Center Study Evaluating Combination of VIDAZA® and REVLIMID® in Higher-Risk MDS Patients Presented at American Society of Hematology
December 13, 2011
 · 
1 min read
Drug Development
Celgene International Sárl Release: Phase III Study with REVLIMID® Continuous Therapy Demonstrates Statistically Significant Improvement in Progression-Free Survival for Patients Newly Diagnosed with Multiple Myeloma
December 13, 2011
 · 
1 min read
Drug Development
Seattle Genetics, Inc. Reports Data From Multiple Presentations on ADCETRIS™ (Brentuximab Vedotin) at American Society of Hematology Annual Meeting
December 12, 2011
 · 
1 min read
Drug Development
Pfizer Inc.'s Failed Blood Cancer Drug Shows Promise in New Subset of AML Patients
December 12, 2011
 · 
1 min read
Drug Development
AMAG Pharmaceuticals, Inc. Announces Preliminary Data Regarding the Safety and Efficacy of a Single Infusion of 1020 mg Ferumoxytol (Feraheme®) in Patients with Iron Deficiency Anemia
December 12, 2011
 · 
1 min read
Drug Development
Celgene International Sárl Release: Dosing Study Evaluates REVLIMID® in Previously Treated Patients with Chronic Lymphocytic Leukemia
December 12, 2011
 · 
1 min read
Drug Development
Celgene International Sárl Release: Results from a Comparative Analysis Shows REVLIMID® Demonstrates Statistically Significant Reduction in Risk of Death and No Evidence of Increased Risk of Progression to AML in Patients with Deletion 5q MDS Compared wit
December 12, 2011
 · 
1 min read
Drug Development
Roche Absorbs New Setback for Avastin as Cancer Treatment
December 9, 2011
 · 
1 min read
Drug Development
GlaxoSmithKline Drug Fails to Hit Goal in Breast Cancer Trial
December 9, 2011
 · 
1 min read
Drug Development
Leading Investigator to Present Clinical Data on Generex Biotechnology Corporation Oral-lyn(TM) at International Diabetes Federation Meetings in Dubai
December 8, 2011
 · 
5 min read
Drug Development
Latest Data on Novartis AG Afinitor Confirms Efficacy
December 8, 2011
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation,Eli Lilly and Company Release: Linagliptin Demonstrates Meaningful Improvement in Glycaemic Control in Initial Combination Therapy with Metformin
December 8, 2011
 · 
1 min read
Drug Development
Novasys Medical, Inc. Release: Three Year Study Proves Renessa(R) Treatment for Stress Incontinence Is Effective, Safe and Durable
December 7, 2011
 · 
3 min read
Drug Development
Novo Nordisk A/S Release: Data Show That the Combination of Insulin Degludec/Insulin Aspart Significantly Reduced Hypoglycaemia in Type 1 and Type 2 Diabetes Patients
December 6, 2011
 · 
1 min read
Drug Development
Pooled Analysis: Fewer Major Adverse Cardiovascular Events in People with Type 2 Diabetes Treated with Merck Sharp & Dohme’s JANUVIA ® (sitagliptin)
December 6, 2011
 · 
7 min read
Drug Development
Discovery Laboratories Release: New Study Shows AFECTAIR(R) Significantly Improved Delivery of Nitric Oxide Under Simulated Neonatal Ventilatory Conditions
December 6, 2011
 · 
4 min read
Drug Development
Pfizer Inc.’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients
December 6, 2011
 · 
1 min read
Drug Development
Pfizer Inc.'s Kidney Cancer Drug May Not Be Effective, FDA Says
December 6, 2011
 · 
1 min read
Drug Development
Mederi Therapeutics Inc. Release: New Data Identifies Stretta(R) Mechanism in the Treatment of Gastroesophageal Reflux Disease (GERD)
December 5, 2011
 · 
2 min read
Load More